Jeff Eidel - 02 Mar 2023 Form 4 Insider Report for PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)

Role
Chief Commercial Officer
Signature
/s/ Michele Farmer, Attorney-in-fact
Issuer symbol
PACB
Transactions as of
02 Mar 2023
Net transactions value
$0
Form type
4
Filing time
06 Mar 2023, 15:39:26 UTC
Previous filing
06 Sep 2022
Next filing
18 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PACB Common Stock Award $0 +164,200 +54% $0.000000 470,602 02 Mar 2023 Direct F1, F2
holding PACB Common Stock 208 02 Mar 2023 By spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal annual installments on February 15th of each of 2024, 2025, 2026, and 2027, provided that the Reporting Person continues to serve through each applicable vesting date.
F2 Includes 5,832 shares purchased on March 1, 2023 under the Company's 2010 Employee Stock Purchase Plan.

Remarks:

Chief Commercial Officer